| Nome |
# |
|
Reazioni avverse e procedure specialistiche - impiego di laser chirurgici, file e14ff6e2-efc5-0209-e053-6605fe0ad24c
|
289
|
|
Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck., file e14ff6e2-f1a0-0209-e053-6605fe0ad24c
|
165
|
|
Anti-tumour necrosis factor-alpha therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study., file e14ff6e2-f1a1-0209-e053-6605fe0ad24c
|
142
|
|
Dupilumab improves clinical manifestations, symptoms, and quality of life in adult patients with chronic nodular prurigo, file e14ff6e5-194d-0209-e053-6605fe0ad24c
|
131
|
|
Tailored biological treatment for patients with
moderate-to-severe psoriasis, file 572e8bc3-d6b5-450f-97c5-3fd15b849b68
|
120
|
|
Dermoscopic features of nevoid
melanoma: a retrospective study, file ec982198-bb4a-42cc-b797-b8ad289e0c46
|
85
|
|
Monkeypox virus infection: what dermatologist needs to know?, file 875f895d-314e-4425-9adc-932c99b04274
|
75
|
|
Acantholytic dyskeratotic acanthoma in an immunosuppressed patient: a case report with review of the literature, file e14ff6e2-f306-0209-e053-6605fe0ad24c
|
71
|
|
Chronic pruritus in the absence of specific skin disease: an update on physiopathology, diagnosis and therapy, file e14ff6e5-257f-0209-e053-6605fe0ad24c
|
69
|
|
Uncommon Non‑Infectious Annular Dermatoses, file 801ecc9f-7231-4fac-97ce-8e5e6ebbb4a2
|
68
|
|
Real-life effectiveness of tildrakizumab in chronic plaque psoriasis:
A 52-week multicentre retrospective study—IL PSO (Italian
landscape psoriasis), file bcac228e-a90e-4f53-847d-70f96d5cf7a5
|
68
|
|
Atopic Dermatitis in the Elderly Population, file 976d5585-3c80-4e66-b995-07d2682e8e61
|
53
|
|
Use of biologics during the COVID-19 pandemic:
lessons learned from psoriasis, file faa0811a-a44c-4aef-a646-134b4c7f80c7
|
41
|
|
Pustular psoriasis with a focus on generalized
pustular psoriasis: classification and diagnostic criteria.
An Italian expert consensus, file c17fc586-73ed-4abe-bd82-f16a6dde101b
|
39
|
|
Analysis of drug utilization and health care resource consumption in patients with psoriasis and psoriatic arthritis before and after treatment with biological therapies, file e14ff6e4-c6f3-0209-e053-6605fe0ad24c
|
39
|
|
Survival, efficacy and safety of tralokinumab after 32 and 52 weeks of treatment for moderate-to-severe atopic dermatitis in adults: A multicentre real-world study, file ffdff002-509b-4592-b737-6520b90c7233
|
39
|
|
A risankizumab super responder profile identified by long-term real-life observation-IL PSO (ITALIAN LANDSCAPE PSORIASIS), file 6a750b3b-9ea7-4b91-8da4-1c5d1ff5eefb
|
38
|
|
Psychological Stress and Salivary Cortisol Levels in Patients with Plaque Psoriasis, file e14ff6e5-d0b8-0209-e053-6605fe0ad24c
|
35
|
|
Comparative dermoscopy assessment of nevus-associated versus de novo in situ melanoma, file a4922823-6942-49fc-a6d1-d4502b5831e8
|
30
|
|
Durability of Response to Abrocitinib in Patients
with Moderate-to-Severe Atopic Dermatitis After
Treatment Discontinuation in a Phase 2b Trial, file 6c8c47dd-7528-4fba-bfc3-0d905d9075bf
|
27
|
|
Advanced Glycation End Products and Psoriasis, file ee36b523-0f3a-47a5-be16-dd46eaea53c7
|
27
|
|
Reduction of cutaneous advanced glycation end products levels after effective psoriasis treatment, file 6370ae43-df4f-4ede-bc63-bddf7d73bd2e
|
24
|
|
The transition from mild to moderate-to-severe chronic plaque psoriasis, file dc44fa6e-b9df-4c3b-bed6-129f8da7c458
|
24
|
|
Incidence and clinical predictors of a subsequent nonmelanoma skin cancer in solid organ transplant recipients with a first nonmelanoma skin cancer: a multicenter cohort study., file e14ff6e2-f19f-0209-e053-6605fe0ad24c
|
23
|
|
Effects of secukinumab on serum adipocytokines: preliminary data, file e14ff6e4-d080-0209-e053-6605fe0ad24c
|
22
|
|
Brodalumab for the treatment of plaque psoriasis in a real-life setting: a 3 years multicenter retrospective study—IL PSO (Italian landscape psoriasis), file 6d504290-1241-4dff-be24-9cc633dcd3e8
|
21
|
|
The Combination of Dupilumab with Other Monoclonal Antibodies, file 7bee7838-9755-4875-ae6d-b42a9dac462e
|
21
|
|
Clinical Characteristics of Patients with Pustular Psoriasis: A Single-Center Retrospective Observational Study, file 0f79581b-3c90-4997-b3dd-7749e575413b
|
20
|
|
Non-melanoma skin cancer in outdoor workers: a study on actinic keratosis in Italian navy personnel, file e14ff6e4-fb69-0209-e053-6605fe0ad24c
|
19
|
|
European guideline (EuroGuiDerm) on atopic eczema – part
II: non-systemic treatments and treatment
recommendations for special AE patient populations, file a6e41cca-3ce8-475b-a1d5-7aa520c941e6
|
17
|
|
A concept for integrated care pathways for atopic dermatitis
—A GA2LEN ADCARE initiative, file b6df89b3-fd77-49ec-960a-7a09e4ed7ba4
|
17
|
|
Eosinophilic annular erythema
successfully treated with cyclosporine, file 0d24f4c2-c6ff-4c76-9410-bc354734c8f2
|
16
|
|
First update of the living European guideline (EuroGuiDerm) on
atopic eczema, file fcb5eca0-f61b-4a69-ac2a-c921d6147ea9
|
16
|
|
Cost per responder of adalimumab biosimilars
versus methotrexate in patients with psoriasis: a
real-life experience, file 04be6acc-79a9-4f8f-82ea-c0203ba995d1
|
15
|
|
Central Pain Sensitization in Patients with Chronic Plaque Psoriasis, file 2c9c4301-087e-450a-9acd-6f14046a496c
|
15
|
|
Current treatment goals are achieved by the
majority of patients with atopic dermatitis treated
with tralokinumab: results from a multicentric,
multinational, retrospective, cohort study, file 3c4b48e1-6cd2-435f-b528-f1d86f9bc3dd
|
15
|
|
Overview of Atopic Dermatitis in Different Ethnic Groups, file f857e258-e25d-482e-bd35-34115762f3e7
|
15
|
|
Allelic Variants of HLA-C Upstream Region, PSORS1C3,
MICA, TNFA and Genes Involved in Epidermal Homeostasis
and Barrier Function Influence the Clinical Response to
Anti-IL-12/IL-23 Treatment of Patients with Psoriasis, file 6c96cfd2-f952-4eec-a02a-a82cdeac1a0f
|
13
|
|
Assessing patients' characteristics and treatment patterns among children with atopic dermatitis, file e14ff6e5-a56c-0209-e053-6605fe0ad24c
|
13
|
|
Cost per responder of Adalimumab biosimilars
MSB11022 and ABP 501 versus the originator and
methotrexate in chronic plaque psoriasis, file f4b12a0d-0fdd-4af0-aa01-fd887a672dca
|
13
|
|
Characteristics of Patients Experiencing a Flare of Generalized
Pustular Psoriasis: A Multicenter Observational Study, file 14f40899-8a8a-4bf4-9f27-2a86ccf52f49
|
11
|
|
Spesolimab in patients with flare of generalized pustular psoriasis: A multicentre case-series, file 21b02853-8084-40e5-9a12-4aa882cd8bb8
|
11
|
|
Real-Life Effectiveness of Adalimumab Biosimilars in Patients with Chronic Plaque Psoriasis, file 82475bed-4d64-4be7-9856-029f06b671f3
|
11
|
|
A man with a widespread bullous eruption, file ace83d8d-f872-4cd7-b817-1a31078ebde9
|
11
|
|
Long-term follow-up of Zoon balanitis: a retrospective cohort study, file d8d27086-40e7-46db-887d-89774da677ee
|
11
|
|
Pili migrans, file e14ff6e5-0318-0209-e053-6605fe0ad24c
|
11
|
|
Association between short-term
exposure to environmental air pollution
and atopic dermatitis flare in patients
treated with dupilumab, file 93766722-bf96-4052-899f-ccf7d3c8ce54
|
10
|
|
Effectiveness, Tolerability, and Drug Survival of Risankizumab
in a Real-World Setting: A Three-Year Retrospective Multicenter
Study—IL PSO (ITALIAN LANDSCAPE PSORIASIS), file c9231a24-956d-4408-8faa-9396f4a01214
|
10
|
|
Characteristics associated with clinical response to Comano thermal spring water balneotherapy in pediatric patients with atopic dermatitis, file e14ff6e5-a56e-0209-e053-6605fe0ad24c
|
10
|
|
Neutrophils inhibit γδ T cell functions in the imiquimod-induced mouse model of psoriasis, file ee9bb30a-604f-4646-bbf0-76b77178eb09
|
10
|
|
Identification of clinical predictors for dupilumab
dose spacing in adults with atopic dermatitis: a
real-world study, file 9610fb7a-9f71-4527-a282-4b6e4e15bec8
|
9
|
|
European consensus statement on phenotypes of pustular psoriasis, file 439f19d1-69a0-4a87-a2ae-3d37b98cd3cd
|
6
|
|
Skin adverse reactions to Sars‐CoV‐2 vaccination: a relevant responsibility issue for dermatologists, file e14ff6e5-dcb8-0209-e053-6605fe0ad24c
|
6
|
|
Awareness of obesity among patients with psoriasis, file 2f5dc5f1-58f1-47cd-a6af-c1a774c9724a
|
5
|
|
Pyoderma gangrenosum associated with pseudo-PelgerHuët anomaly in a patient with idiopathic myelofibrosis, file 5540242d-0183-40f8-9dcb-85255418ee07
|
5
|
|
Prevalence of Non-Alcoholic Fatty Liver Disease in Adult Individuals with Moderate-to-Severe Atopic Dermatitis, file 9b677499-4f3d-442a-8a9c-ef7c321c7bc1
|
5
|
|
Beneficial effects of upadacitinib on alopecia areata associated with atopic dermatitis: A multicenter retrospective study Table I. Baseline emographic and clinical characteristics of patients with AD and concomitant AA Items N = 19, file 0ca7430d-9e3f-4206-b9a2-5f18e035dca3
|
4
|
|
Fast and safe clinical response to sonidegib in a 98-year-old
woman affected by locally advanced basal cell carcinoma, file a9912c2c-2064-47b0-98f8-d5d50c5fe0a4
|
4
|
|
Price variability of TNF-α inhibitor biosimilars among European countries, file ae501b07-8361-47eb-aaba-034718fd591e
|
4
|
|
Long-Term Drug Survival and Effectiveness of Secukinumab in Patients with Moderate to Severe Chronic Plaque Psoriasis: 42-Month Results from the SUPREME 2.0 Study, file d7d27c6d-dd9c-4bc8-9dfc-0161e6e4d9a8
|
4
|
|
Cover Quizlet, file e14ff6e3-1c27-0209-e053-6605fe0ad24c
|
4
|
|
BRAF V600E expression in juvenile xanthogranuloma occurring after Langerhans cell histiocytosis., file e14ff6e4-8946-0209-e053-6605fe0ad24c
|
4
|
|
Place of apremilast in the real-life treatment of patients with plaque psoriasis, file e14ff6e5-86fa-0209-e053-6605fe0ad24c
|
4
|
|
IL-17A inhibitors in patients with chronic plaque psoriasis and
history of malignancy: A case series with systematic literature
review, file e14ff6e5-a6cd-0209-e053-6605fe0ad24c
|
4
|
|
Drug survival of IL-12/23, IL-17
and IL-23 inhibitors for
moderate-to-severe plaque
psoriasis: a retrospective
multicenter real-world
experience on 5932 treatment
courses – IL PSO (Italian
landscape psoriasis), file 61ba9b98-09bd-498b-85d3-52f397fc95bd
|
3
|
|
Adalimumab in the management of psoriasis and psoriatic arthritis: Results from a Delphi investigation, file c1f3136a-ba0d-4b11-9b8f-b3d123e4120f
|
3
|
|
Recurrent cutaneous eosinophilic vasculitis
characterized by annular purpuric lesions: A
case report, file e0679c77-b6a4-489c-9576-fcb386475c0d
|
3
|
|
Epidermal growth factor receptor signalling in keratinocyte biology: implications for skin toxicity of tyrosine kinase inhibitors, file e14ff6e2-ee0b-0209-e053-6605fe0ad24c
|
3
|
|
Chromatin remodelling and autocrine TNFα are required for optimal interleukin-6 expression in activated human neutrophils, file e14ff6e3-8cf6-0209-e053-6605fe0ad24c
|
3
|
|
A Reappraisal on the Potential Ability of Human Neutrophils to Express and Produce IL-17 Family Members In Vitro: Failure to Reproducibly Detect It, file e14ff6e4-34fd-0209-e053-6605fe0ad24c
|
3
|
|
Clinical features and treatments of transient acantholytic dermatosis (Grover’s disease): a systematic review, file e14ff6e5-3dcc-0209-e053-6605fe0ad24c
|
3
|
|
Cutaneous Adverse Reactions Associated with SARS-CoV-2 Vaccines, file e14ff6e5-d10d-0209-e053-6605fe0ad24c
|
3
|
|
Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate‑to‑Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO‑2, file ec1d7a91-d85e-420f-b009-30c3eda078a7
|
3
|
|
Increasing Access to Effective Systemic Treatments
in Patients with Moderate-to-Severe Psoriasis:
Narrative Review, file 09751733-950b-4003-9143-c3b53ff36f2b
|
2
|
|
A case of genital primary syphilis with superimposed impetigo, file 75357bed-83c9-47f8-a53d-28ce47eef766
|
2
|
|
Cantú syndrome: A new case and evolution of clinical conditions during first 2-year follow-up, file 99260491-61f7-4bcc-b3e6-17ddfea3354a
|
2
|
|
Shedding Light on Novel Pathogenic and Therapeutic Aspects
Related to Immune-Mediated Skin Diseases, file 99552977-4680-48f9-84fc-655621063cc1
|
2
|
|
Cantú syndrome: A new case and evolution of clinical conditions during first 2-year follow-up, file aae00769-9176-46c1-b9cc-8400298eeaae
|
2
|
|
Upadacitinib in patients with resistant atopic dermatitis: a retrospective case-series, file ad4a4e8f-8114-473d-b238-619a24540883
|
2
|
|
Association of functional gene variants in the regulatory regions of COX-2 gene (PTGS2) with nonmelanoma skin cancer after organ transplantation., file e14ff6e2-de51-0209-e053-6605fe0ad24c
|
2
|
|
Chronic pruritus in the absence of specific skin disease: an update on physiopathology, diagnosis and therapy, file e14ff6e2-e68c-0209-e053-6605fe0ad24c
|
2
|
|
Systemic therapy of psoriasis in diabetic patients, file e14ff6e3-007a-0209-e053-6605fe0ad24c
|
2
|
|
Single organ cutaneous vasculitis: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data, file e14ff6e3-b053-0209-e053-6605fe0ad24c
|
2
|
|
Unexplored diversity and strain-level structure of the skin microbiome associated with psoriasis, file e14ff6e3-e179-0209-e053-6605fe0ad24c
|
2
|
|
Treatment Approaches to Moderate to Severe Psoriasis, file e14ff6e3-f529-0209-e053-6605fe0ad24c
|
2
|
|
Incidence and ten-year follow-up of primary cutaneous lymphomas: a single-centre cohort study, file e14ff6e4-227f-0209-e053-6605fe0ad24c
|
2
|
|
Etanercept biosimilar SB4 in the treatment of chronic plaque psoriasis: data from the Psobiosimilars registry, file e14ff6e4-8289-0209-e053-6605fe0ad24c
|
2
|
|
Increased red blood cell distribution width in patients with plaque psoriasis, file e14ff6e5-772a-0209-e053-6605fe0ad24c
|
2
|
|
Nivolumab induced morphea, file e14ff6e5-7e89-0209-e053-6605fe0ad24c
|
2
|
|
A case of porokeratosis with predominant follicular involvement, file e14ff6e5-e494-0209-e053-6605fe0ad24c
|
2
|
|
Idiopathic lichenoid and granulomatous dermatitis, file e14ff6e5-eb9b-0209-e053-6605fe0ad24c
|
2
|
|
Lymphoplasmacytic plaque effectively treated with imiquimod, file e14ff6e5-edd7-0209-e053-6605fe0ad24c
|
2
|
|
Sharing Patient and Clinician Experiences ofModerate-to-Severe Psoriasis: A Nationwide Italian Survey and Expert Opinion to Explore Barriers Impacting upon PatientWellbeing, file e14ff6e6-0dcf-0209-e053-6605fe0ad24c
|
2
|
|
Predictors of subsequent primary melanoma: a case-control study, file 4581514b-950e-4b15-aede-c8478cf9bd28
|
1
|
|
Reducing the Risk of Developing Psoriatic Arthritis in Patients with Psoriasis, file 46de0854-fec8-44f4-b68e-b588e734cf4e
|
1
|
|
The Treat-to-Target Project in Atopic Dermatitis: One Year On, file 4ebc2de5-2c06-4606-8241-44a38b51c2c1
|
1
|
|
Non-Alcoholic Fatty Liver Disease Is Associated With Reduced Glomerular Filtration Rate in Patients With Chronic Plaque Psoriasis, file 5ce8665b-0ba9-4310-abde-58cd2f3f0176
|
1
|
|
Risk of non-alcoholic fatty liver disease in patients with chronic plaque psoriasis: an updated systematic review and meta-analysis of observational studies, file 90e623bc-2a79-4a32-acac-70256ce4b6e9
|
1
|
|
Cutaneous Adverse Reactions to SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis, file 9a70badf-254d-4221-909b-06028058d9d0
|
1
|
|
Psoriasis beyond the skin: an expert group consensus on
the management of psoriatic arthritis and common
co-morbidities in patients with moderate-to-severe psoriasis, file e14ff6e2-efbd-0209-e053-6605fe0ad24c
|
1
|
| Totale |
2.238 |